Future-Proofing Biopharma Procurement Amid Growing External Complexity

Building Resilient Supplier Relationships, Leveraging AI-Driven Efficiency & Maximizing Value Through More Strategic Procurement

R&D procurement has never carried more weight. Outsourcing now accounts for roughly a quarter of pharma R&D costs, and supplier consolidation is shrinking your options. Tariffs and the BIOSECURE Act are redrawing global supply chains, and your team is expected to deliver more with the same headcount. 

The 11th R&D Procurement & Sourcing in Pharma Summit returns to Boston as the only event built exclusively for biopharma R&D procurement. It unites clinical, preclinical and strategic sourcing leaders from pharma and biotech in one focused, single-track room. The summit is pharma- and biotech-led, never vendor-led, with real case studies, candid peer discussion and interactive sessions where you build, not just listen. 

New for 2027, the AI Real-World Implementation Day moves AI from pilot to practice. Benchmark your AI maturity against peers, see live deployments and build your own agentic workflow before you leave. 

The summit arrives less than three months after the first BIOSECURE list of biotechnology companies of concern is due. That makes it your moment to stress-test your supply base and sharpen your category strategy. You’ll return with a completed vendor scorecard, practical strategies for tariffs and scarce capacity, and a network of peers facing the same challenges you do. 

Enjoyed connecting with procurement peers and gaining insight into how different organizations are embedding AI into both day-to-day operations and broader strategic initiatives. The discussions were highly engaging and thought-provoking, and the energy and enthusiasm throughout the event made it a particularly valuable experience.

Director, Sourcing & Procurement, Biote

Biote Logo

The networking opportunities and chance to exchange ideas with fellow procurement professionals were among the most valuable aspects of the event. I particularly appreciated the strong focus on real-world Pharma and Biotech experiences, with discussions centred on practical R&D procurement challenges, strategies, and solutions.

Senior Director, Global R&D Procurement, Chiesi Farmaceutici

Chiesi

The topics were highly relevant to the current challenges and opportunities facing Clinical R&D sourcing. The diversity of speakers, representing both large and emerging organizations, brought a broad range of perspectives that helped foster greater alignment across the industry. Hearing how different companies are approaching similar issues made the discussions especially insightful and practical.

Associate Director - Global Sourcing and Procurement, Research & Development Services, BioMarin Pharmaceutical 

BioMarin logo displayed as a testimonial provider for the 11th R&D Procurement & Sourcing in Pharma Summit.

Well organized, interaction among attendees facilitated by organizers was excellent, interesting talks.

Vice President - Global Pharma Sales, Specs

What you missed:

Strengthening global sourcing resilience with business continuity models that withstand geopolitical, tariff, and supply chain disruption

Maximizing supplier partnership value through transparent governance, long-term alignment, and performance-driven collaboration

Operationalizing AI and orchestration tools to streamline sourcing, contracting, and vendor management workflows

Elevating procurement’s influence in R&D by embedding strategic decision-making earlier in the clinical development process

Enhancing contracting, PO management, and KPI frameworks to drive executional excellence across global trial portfolios

Across the three days of collaborative workshops, case studies, and practical sessions, those who participated gained the strategies needed to accelerate study timelines, modernize procurement operating models, and build robust supplier ecosystems that deliver measurable impact for their R&D pipeline.

Explore The Full Event Guide

  • Strengthen supplier partnerships with proven SRM frameworks that enhance transparency, trust, and long-term value
  • Leverage AI and digital procurement tools to streamline sourcing, contracting, and operational workflows across R&D
  • Align strategic and tactical teams through our dual-track agenda designed to elevate leadership and execution capabilities
  • Deploy resilient procurement strategies that mitigate risk, enhance continuity, and support global R&D acceleration
  • Benchmark KPI models to drive measurable performance, improve governance, and optimize supplier contributions across the value chain
70257 (1)

More Than a Meeting:

80+

Procurement Leaders from Pharma, Biotech, CRO, and beyond

24+

Expert Speakers Shaping the Future of R&D Procurement

8+

Hours of Structured Networking

3

Days of Actionable Insights and Peer Learning

1

Dedicated Workshop for AI Orchestration in Procurement

Official Partners

R&D Procurement & Sourcing in Pharma - Brochure Cover
Quick Download

Attending Companies Include

GSK
bayer logo
Regeneron
Astellas
Roche logo
Vertex logo
Takeda
Chiesi
Abbvie
Image of Summit - R&D Procurement & Sourcing in Pharma
Explore the Agenda

Attendees discovered practical strategies from leading R&D procurement, sourcing, and category experts through case studies, interactive discussions, and hands-on workshops. The summit equipped participants to elevate supplier partnerships, streamline operations, and future-proof procurement in a rapidly shifting landscape.

Image of Networking at R&D Procurement & Sourcing in Pharma
Partner With Us

Showcase how your technology or services accelerate smarter R&D procurement, from AI-driven sourcing and contracting tools to e-marketplaces, lab services, and risk management platforms, and connect directly with decision-makers shaping next-generation procurement excellence.

Image of R&D Procurement & Sourcing in Pharma
Join the R&D Procurement Community

Be part of the only summit uniting 130+ pharma, biotech, and CRO procurement leaders. Exchange real-world insights, benchmark against industry innovators, and collaborate on the strategies redefining supplier value, operational agility, and pipeline acceleration.